Category Archives: General HIV- population
Reviews on HIV- people that explore topics including risk, screening, and prevention
A systematic review of palliative care intervention outcomes and outcome measures in low resource countries
CONTEXT: To meet the growing need for palliative care in low-resource countries, palliative care programs should be evidence-based and contextually appropriate. This study was conducted to synthesize the current evidence...
Building a conceptual framework to study the effect of HIV stigma-reduction intervention strategies on HIV test uptake: A scoping review
A scoping review of grey and peer-reviewed literature was conducted to develop a conceptual framework to illustrate mechanisms involved in reducing HIV stigma and increasing HIV test uptake. We followed...
Interventions that address intimate partner violence and HIV among women: A systematic review
Recognizing the high prevalence of human immunodeficiency virus (HIV)-positive women and girls who are either at risk for or suffer from intimate partner violence (IPV) and the overlapping challenges posed...
HIV risk inside U.S. prisons: A systematic review of risk reduction interventions conducted in U.S. prisons
HIV prevalence in correctional populations is approximately five times that of the general adult population. This systematic review examines the broad question of HIV prevention and interventions to reduce inmate...
Review of toxoplasmosis in Morocco: Seroprevalence and risk factors for toxoplasma infection among pregnant women and HIV- infected patients
Toxoplasmosis is a disease caused by a protozoal parasite: Toxoplasma gondii. This infection can cause severe illness when the organism is contracted congenitally or when it is reactivated in immunosuppressed...
Tenofovir disoproxil fumarate safety for women and their infants during pregnancy and breastfeeding
OBJECTIVES: Pregnant/lactating women in some sub-Saharan Africa settings are at substantial risk of HIV acquisition and could benefit from preexposure prophylaxis (PrEP) with tenofovir disoproxil fumarate (TDF), but safety data...
